BFTP SEP Board Member Wins Prestigious Award
Pennsylvania Bio plans to honor Brenda D. Gavin, a partner at Philadelphia-based Quaker BioVentures, with its Hubert J.P. Schoemaker Leadership Award at its 2010 annual dinner and awards celebration on March 11 at the Pennsylvania Convention Center in Philadelphia.
Brenda Gavin, partner at Philadelphia-based Quaker BioVentures
Dennis M. “Mickey” Flynn, president of the Malvern-based industry trade group, said the Schoemaker Award — named for the late Centocor co-founder and one of the region’s biotechnology industry entrepreneurs — is awarded annually to “visionary leaders” in the local bio-tech arena.
“Brenda has helped to shape and grow the way we invest in bioscience companies,” Flynn says. “She is widely sought after for her expertise and commitment to the needs of entrepreneurs, and we’re incredibly fortunate to have this globally recognized talent in our region, contributing to the growth of our community.”
A founding partner of the venture capital firm Quaker BioVentures, Gavin previously served as president of SR One Ltd., GlaxoSmithKline’s venture capital arm, and as general partner of EuclidSR Partners, an independent venture capital fund focused on health-care and information technology. Among the many boards Brenda sits on is the board of directors for the Ben Franklin Technology Partners of Southeastern Pennsylvania.
The recipient of the award is selected by Pennsylvania Bio’s Board of Directors. Past winners have been Frank Baldino Jr., chairman and CEO of Cephalon; David Holveck, president and CEO of Endo Pharmaceuticals; Jean-Pierre Garnier, former CEO of GlaxoSmithKline; and Joseph Scodari, former worldwide chairman of the Johnson & Johnson Pharmaceuticals Group.
More information on the Pennsylvania Bio 2010 annual dinner can be found at www.pennsylvaniabio.org
Tags: BFTP board announcements, biotechnology, venture capital, filed under News, Southeastern PA 